FDA Approves mirabegron for Neurogenic Detrusor Overactivity in kids Dr. Kamal Kant Kohli26 March 2021 10:00 AM ISTOveractive bladder is a bladder dysfunction related to neurological impairment.The U.S. Food and Drug Administration has approved a new indication for...
FDA grants fast Track Designation to human stem cell therapy for Type 1 Diabetes Dr. Kamal Kant Kohli11 March 2021 4:15 PM ISTThe U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to VX-880, a human stem cell-derived therapy for patients with type 1...
FDA approves wearable device for Treatment of acute Israelne Dr. Kamal Kant Kohli6 March 2021 8:55 AM ISTIsrael: Food and Drug Administration (FDA) has cleared Relivion® system, the first non-invasive multi-channel brain neuromodulation system for at home...
FDA approves new gene therapy for non-Hodgkin lymphomas Dr. Kamal Kant Kohli6 Feb 2021 4:02 AM ISTThe U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain...
FDA approves first once a month injectable treatment for HIV patients Dr. Kamal Kant Kohli22 Jan 2021 3:48 AM ISTThe U.S. Food and Drug Administration has approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as an extended release complete...
FDA approves VERQUVO to treat Chronic Heart Failure Dr. Kamal Kant Kohli21 Jan 2021 8:31 AM ISTThe US Food and Drug Administration (FDA) has granted approval to vericiguat (VERQUVO) for the reduced risk of cardiovascular death and heart failure...
FDA approves generic version of Glucagon for tackling hypoglycemia Dr. Kamal Kant Kohli29 Dec 2020 10:15 AM ISTThe U.S. Food and Drug Administration has approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the...
FDA approves vibegron for overactive bladder in adults Dr. Kamal Kant Kohli26 Dec 2020 10:00 AM ISTThe food and drug administration has granted approval to vibegron (Gemtesa) for the treatment of adult patients with overactive bladder (OAB) with...
FDA Approves Topical Treatment for Actinic Keratosis Medha Baranwal23 Dec 2020 11:45 AM ISTThe the US Food and Drug Administration (FDA) has approved Almirall's Tirbanibulin (Klisyri) as a topical treatment for actinic keratosis (AK). The...
FDA Approves first Oral Hormone Therapy for Treating Advanced Prostate Cancer Hina Zahid20 Dec 2020 8:43 PM ISTThe FDA has approved relugolix an oral androgen deprivation therapy ADT for men with advanced prostate cancer. The FDA granted approval of Orgovyx to...
FDA approves osimertinib for treatment of non-small cell lung cancer Hina Zahid20 Dec 2020 7:45 AM ISTThe U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer...
FDA grants EUA to Moderna vaccine for prevention of COVID-19 Dr. Kamal Kant Kohli19 Dec 2020 7:47 AM ISTThe U.S. Food and Drug Administration has issued an emergency use authorization (EUA) to Moderna COVID-19 Vaccine for the prevention of COVID-19...
